COST

922.7

-0.28%↓

PG

147.73

-0.13%↓

KO

71.12

+0.04%↑

PM

155.01

-0.13%↓

PEP

145.82

+0.59%↑

COST

922.7

-0.28%↓

PG

147.73

-0.13%↓

KO

71.12

+0.04%↑

PM

155.01

-0.13%↓

PEP

145.82

+0.59%↑

COST

922.7

-0.28%↓

PG

147.73

-0.13%↓

KO

71.12

+0.04%↑

PM

155.01

-0.13%↓

PEP

145.82

+0.59%↑

COST

922.7

-0.28%↓

PG

147.73

-0.13%↓

KO

71.12

+0.04%↑

PM

155.01

-0.13%↓

PEP

145.82

+0.59%↑

COST

922.7

-0.28%↓

PG

147.73

-0.13%↓

KO

71.12

+0.04%↑

PM

155.01

-0.13%↓

PEP

145.82

+0.59%↑

Search

USANA Health Sciences Inc

Slēgts

19.18 -0.62

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

19.03

Max

19.21

Galvenie mērījumi

By Trading Economics

Ienākumi

-17M

-6.7M

Pārdošana

-22M

214M

P/E

Sektora vidējais

21.311

28.248

EPS

-0.15

Peļņas marža

-3.118

Darbinieki

1,700

EBITDA

-17M

11M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+101.34% upside

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-31M

351M

Iepriekšējā atvēršanas cena

19.8

Iepriekšējā slēgšanas cena

19.18

Tehniskais rādītājs

By Trading Central

Pārliecība

Weak Bullish Evidence

USANA Health Sciences Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 14. nov. 17:45 UTC

Peļņas
Galvenie tirgus virzītāji

Figure Technology Shares Rise After Higher 3Q Earnings, Revenue

2025. g. 14. nov. 17:31 UTC

Peļņas
Galvenie tirgus virzītāji

American Bitcoin Advances on 3Q Profit, Eric Trump's Crypto Confidence

2025. g. 14. nov. 16:15 UTC

Galvenie tirgus virzītāji

Scholar Rock Shares Rise on Renewed Apitegromab Hopes

2025. g. 14. nov. 23:56 UTC

Iegādes, apvienošanās, pārņemšana

Berkshire Hathaway Bought Alphabet Shares Worth $4.3 Billion in the Third Quarter. Here's What It Sold. -- Barrons.com

2025. g. 14. nov. 23:02 UTC

Tirgus saruna

Chinese Battery Makers Benefit From U.S. Rising Demand -- Market Talk

2025. g. 14. nov. 22:35 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

The Score: Tyson, Robinhood, Walmart, Paramount Skydance and More Stocks That Defined the Week -- WSJ

2025. g. 14. nov. 22:32 UTC

Iegādes, apvienošanās, pārņemšana

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 2nd Update

2025. g. 14. nov. 22:29 UTC

Peļņas

Starbucks Scores on Holiday Sales. It's a Good Sign for the Turnaround. -- Barrons.com

2025. g. 14. nov. 22:00 UTC

Iegādes, apvienošanās, pārņemšana

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- Update

2025. g. 14. nov. 21:50 UTC

Tirgus saruna
Peļņas

Tech, Media & Telecom Roundup: Market Talk

2025. g. 14. nov. 21:18 UTC

Iegādes, apvienošanās, pārņemšana

Berkshire Buys Shares of Alphabet and Pares Apple Stake -- WSJ

2025. g. 14. nov. 20:27 UTC

Tirgus saruna

Oil Futures Rise After Ukraine Strikes Russian Port -- Market Talk

2025. g. 14. nov. 20:23 UTC

Tirgus saruna

U.S. Natural Gas Futures Post Weekly Gain -- Market Talk

2025. g. 14. nov. 20:17 UTC

Iegādes, apvienošanās, pārņemšana

Several State Attorneys General Oppose Railroad Merger -- WSJ

2025. g. 14. nov. 19:29 UTC

Tirgus saruna
Peļņas

Applied Materials' F4Q Results Seen as 'Uninspiring' -- Market Talk

2025. g. 14. nov. 18:44 UTC

Tirgus saruna
Peļņas

Disney's Growth Now Hinges More on ESPN -- Market Talk

2025. g. 14. nov. 18:27 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 14. nov. 18:27 UTC

Tirgus saruna

Morgan Stanley Sees 'Worthy Successor' in Walmart CEO Furner -- Market Talk

2025. g. 14. nov. 18:20 UTC

Tirgus saruna

U.S. Oil Rig Count Rises by 3 to 417 -- Market Talk

2025. g. 14. nov. 17:20 UTC

Tirgus saruna
Peļņas

Auto & Transport Roundup: Market Talk

2025. g. 14. nov. 17:20 UTC

Tirgus saruna
Iegādes, apvienošanās, pārņemšana

Health Care Roundup: Market Talk

2025. g. 14. nov. 17:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2025. g. 14. nov. 16:51 UTC

Tirgus saruna

Starbucks Gets Holiday Sales Lift -- Market Talk

2025. g. 14. nov. 16:48 UTC

Tirgus saruna

Gold Slides Amid Selloff, Lower December Fed Rate-Cut Expectations -- Market Talk

2025. g. 14. nov. 16:38 UTC

Tirgus saruna

Unica Reports Higher Brazilian Sugar and Ethanol Production -- Market Talk

2025. g. 14. nov. 16:30 UTC

Iegādes, apvienošanās, pārņemšana

Merck Is Paying Up for Flu Biotech as M&A Spree Continues -- Barrons.com

2025. g. 14. nov. 16:28 UTC

Tirgus saruna

Ukraine Strike on Russian Port Lifts Distillates -- Market Talk

2025. g. 14. nov. 15:59 UTC

Tirgus saruna

U.S. Natural Gas Inventories Rise More Than Expected -- Market Talk

2025. g. 14. nov. 15:06 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 14. nov. 15:06 UTC

Tirgus saruna

Dollar Could Benefit From U.K., French Fiscal Concerns -- Market Talk

Salīdzinājums

Cenas izmaiņa

USANA Health Sciences Inc Prognoze

Cenas mērķis

By TipRanks

101.34% augšup

Prognoze 12 mēnešiem

Vidējais 39 USD  101.34%

Augstākais 39 USD

Zemākais 39 USD

Pamatojoties uz 1 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi USANA Health Sciences Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

1 ratings

0

Pirkt

1

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

28.405 / 29.84Atbalsts un pretestība

Īstermiņā

Weak Bullish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

No Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat